Alexander Annenkov

419 total citations
15 papers, 328 citations indexed

About

Alexander Annenkov is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Alexander Annenkov has authored 15 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Alexander Annenkov's work include CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virus-based gene therapy research (3 papers). Alexander Annenkov is often cited by papers focused on CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virus-based gene therapy research (3 papers). Alexander Annenkov collaborates with scholars based in United Kingdom, Argentina and Belgium. Alexander Annenkov's co-authors include Yuti Chernajovsky, Rizgar A. Mageed, Manuela Mengozzi, Zelig Eshhar, Pietro Ghezzi, Nancy Hogg, Ilaria Cervellini, Susan Ortlepp, Paul Van Hummelen and Serhat Erbayraktar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Frontiers in Immunology.

In The Last Decade

Alexander Annenkov

15 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Annenkov United Kingdom 10 100 96 93 59 46 15 328
Koichi Murakami Japan 13 135 1.4× 70 0.7× 101 1.1× 56 0.9× 40 0.9× 30 495
Mauro Togni Germany 11 134 1.3× 241 2.5× 98 1.1× 32 0.5× 27 0.6× 19 545
Scott Foster United States 11 158 1.6× 56 0.6× 42 0.5× 48 0.8× 43 0.9× 11 440
Olivier Goupille France 12 175 1.8× 41 0.4× 80 0.9× 54 0.9× 32 0.7× 18 331
Daniel Chesik Netherlands 15 132 1.3× 61 0.6× 35 0.4× 60 1.0× 43 0.9× 20 439
Amennai Daniel Beyeen Sweden 11 85 0.8× 133 1.4× 58 0.6× 34 0.6× 19 0.4× 11 295
Karim L. Kreft Netherlands 13 104 1.0× 141 1.5× 59 0.6× 27 0.5× 17 0.4× 24 408
Darlene Badgett United States 13 213 2.1× 140 1.5× 156 1.7× 11 0.2× 38 0.8× 18 657
Sarah Pasquin Canada 10 116 1.2× 93 1.0× 81 0.9× 22 0.4× 24 0.5× 16 293
Yujun Pan China 11 146 1.5× 157 1.6× 30 0.3× 27 0.5× 40 0.9× 16 433

Countries citing papers authored by Alexander Annenkov

Since Specialization
Citations

This map shows the geographic impact of Alexander Annenkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Annenkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Annenkov more than expected).

Fields of papers citing papers by Alexander Annenkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Annenkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Annenkov. The network helps show where Alexander Annenkov may publish in the future.

Co-authorship network of co-authors of Alexander Annenkov

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Annenkov. A scholar is included among the top collaborators of Alexander Annenkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Annenkov. Alexander Annenkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mengozzi, Manuela, et al.. (2014). Definition of a Family of Tissue-Protective Cytokines Using Functional Cluster Analysis: A Proof-of-Concept Study. Frontiers in Immunology. 5. 115–115. 4 indexed citations
2.
Annenkov, Alexander. (2013). Receptor Tyrosine Kinase (RTK) Signalling in the Control of Neural Stem and Progenitor Cell (NSPC) Development. Molecular Neurobiology. 49(1). 440–471. 21 indexed citations
3.
Cervellini, Ilaria, et al.. (2013). Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor. Molecular Medicine. 19(1). 223–229. 23 indexed citations
4.
Mengozzi, Manuela, Ilaria Cervellini, Pia Villa, et al.. (2012). Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proceedings of the National Academy of Sciences. 109(24). 9617–9622. 72 indexed citations
5.
Annenkov, Alexander, Sandra Amor, Dun Zhou, et al.. (2011). A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligodendrocyte progenitors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(8). 1428–1437. 3 indexed citations
6.
Annenkov, Alexander. (2009). The Insulin-Like Growth Factor (IGF) Receptor Type 1 (IGF1R) as an Essential Component of the Signalling Network Regulating Neurogenesis. Molecular Neurobiology. 40(3). 195–215. 55 indexed citations
7.
Clark, Joanna M., et al.. (2004). T cell receptor ζ reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor α. Proceedings of the National Academy of Sciences. 101(6). 1696–1701. 22 indexed citations
9.
Annenkov, Alexander, et al.. (2002). Highly efficient gene transfer into antigen‐specific primary mouse lymphocytes with replication‐deficient retrovirus expressing the 10A1 envelope protein. The Journal of Gene Medicine. 4(2). 133–140. 7 indexed citations
10.
Chernajovsky, Yuti, Hanna Dreja, Gordon Daly, et al.. (2000). Immuno- and genetic therapy in autoimmune diseases. Genes and Immunity. 1(5). 295–307. 11 indexed citations
11.
Annenkov, Alexander & Yuti Chernajovsky. (2000). Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta. Gene Therapy. 7(8). 714–722. 28 indexed citations
12.
Chernajovsky, Yuti, David Gould, Alexander Annenkov, et al.. (1999). Immunotherapy of auto-immune diseases by gene transfer. Biochemical Society Transactions. 27(6). 869–873. 4 indexed citations
14.
Annenkov, Alexander, et al.. (1998). Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit.. PubMed. 161(12). 6604–13. 27 indexed citations
15.
Annenkov, Alexander, Susan Ortlepp, & Nancy Hogg. (1996). The β2 integrin Mac‐1 but not p150,95 associates with FcγRIIA. European Journal of Immunology. 26(1). 207–212. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026